I know there is both a growing interest in – and quite a bit of confusion about – the state of COVID-19 antibody testing. I wanted to take a moment to clear up some of the confusion.

The therapeutic antibody industry has been propelled by ... the details of which are discussed in this focus issue of Nature Reviews Immunology. In their Timeline article, Alain Beck, Thierry ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

but the extent of these reviews are still uncertain. New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the ...

A UK study finds detectable antibodies reduce COVID-19 infection and severity in immunosuppressed individuals, highlighting ...

Highlighted by Genentech's recent US regulatory submission for trastuzumab–DM1, antibody–drug conjugation technology could be heading for the mainstream in anticancer drug development.

Antibodies, also known as immunoglobulins (IGs), are glycoproteins produced in response to an immune reaction and exhibit high specificity for the antigens that elicit the response. An antibody ...

The results can inform a doctor if a person has an elevated level of thyroglobulin antibodies, which could indicate autoimmune diseases or cancer. This article reviews the TgAb test, what to ...

Company plans to initiate a Phase 1/b trial in relapsed/refractory, locally advanced/metastatic bladder cancer by year-end ...

Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.